![]() |
Quizartinib
- 英文名称:Quizartinib
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B11418
- cas:950769-58-1
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-04-30
产品详请
产地 | 进口 |
品牌 | WYTSCI |
货号 | WT-AY-B11418 |
用途 | 科研检测 |
英文名称 | Quizartinib |
包装规格 | 1MG |
CAS编号 | 950769-58-1 |
别名 | Quizartinib |
纯度 | 98+% |
分子式 | |
是否进口 | 是 |
纯度:98% by HPLC
分子式:C29H32N6O4S
分子量:560.67
溶剂:DMSO (>25 mg/ml)
性状:Off-whtie solid
存储:-20°C
Activity (short version):FLT3 inhibitor
Function / Pharmacology:Quizartinib is a potent and selective inhibitor of FLT3 (Kd = 1.6nM, IC50 = 0.56 nM MV4-11 cells).1 It is in clinical trials for treatment of Acute Myelogenous Leukemia (AML).2,3 Quizartinib priming resulted in prevention of myelosuppression in mice treated with 5-FU and Gemcitabine.4 Quizartinib showed significant reversal of ABCG2-mediated multidrug resistance (@ 3 μM) via antagonism of drug efflux function.5,6
分子式:C29H32N6O4S
分子量:560.67
溶剂:DMSO (>25 mg/ml)
性状:Off-whtie solid
存储:-20°C
Activity (short version):FLT3 inhibitor
Function / Pharmacology:Quizartinib is a potent and selective inhibitor of FLT3 (Kd = 1.6nM, IC50 = 0.56 nM MV4-11 cells).1 It is in clinical trials for treatment of Acute Myelogenous Leukemia (AML).2,3 Quizartinib priming resulted in prevention of myelosuppression in mice treated with 5-FU and Gemcitabine.4 Quizartinib showed significant reversal of ABCG2-mediated multidrug resistance (@ 3 μM) via antagonism of drug efflux function.5,6